BrainCells plans to partner our mGluR2/3 antagonism program with a leading company in the CNS field. We seek a partner with extensive development and commercialization capabilities on a worldwide basis.
Direct partnership inquiries to:
Robert F. Williamson, Acting CEO: firstname.lastname@example.org
Susan E. Dube’, Acting CBO: email@example.com
Contact: 858-812-7700 | © 2011 BrainCells Inc. All rights reserved.